[Anesthetic management in a case of recurrent mediastinal paraganglioma].
Alamán Orbañanos
B
B
Negrete Calderón
N
N
Martín-Romo Capilla
J
J
Becerra Cayetano
A
A
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000768:Anesthesia, General / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D007431:Intraoperative Complications / Q000517:prevention & control*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008479:Mediastinal Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D010235:Paraganglioma / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D010643:Phenoxybenzamine / Q000008:administration & dosage* / Q000627:therapeutic use; D011229:Preanesthetic Medication; D011433:Propranolol / Q000008:administration & dosage* / Q000627:therapeutic use; D013123:Spinal Fusion; D013125:Spinal Neoplasms / Q000556:secondary* / Q000601:surgery; D013904:Thoracic Vertebrae / Q000601:surgery*; D013908:Thoracotomy
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D007457:Iodine Radioisotopes; D010643:Phenoxybenzamine; D019797:3-Iodobenzylguanidine; D011433:Propranolol